Patient advocates explain why the Pediatric Priority Review Voucher (PPRV) Program must be reauthorized, and National Ag Day highlights the links between biotech and agriculture. (982 words, 4 minutes ...

BIO President & CEO John F. Crowley writes Congress to urge PPRV passage; plus a deep dive into the impact of autoimmune disease on women. (761 words, 3 minutes, 48 seconds) “It is critical to pass ...

WASHINGTON D.C. (February 25, 2025) – John Crowley, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement after Representatives Gregory Murphy (R-NC), ...

We’re getting ready for Rare Disease Day (February 28) with a look at how policy can support patients and how BIO is engaging with the FDA. (960 words, 4 minutes, 48 seconds) Ahead of Rare Disease Day ...

A busy week in Washington, D.C., brought legislation to fix the Inflation Reduction Act “pill penalty,” bipartisan calls for PBM reform, and BIO CEO John F. Crowley explaining why Congress needs to ...

ICYMI: PBM legislation was reintroduced in the Senate. We have details, plus more on the biotech market outlook, the importance of Accelerated Approval, and what a new shrimp vaccine tells us about ...

At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the ...

BIO is the world’s largest advocacy association representing biotechnology companies, academic and research institutions, state biotechnology centers and related organizations across the United States ...

How can BIO help you make your mark? A membership with BIO gives you a powerful voice to help advance your science and enact meaningful change.

BIO Business Solutions ® is the largest cost savings purchasing program for the biotech industry operated by the Biotechnology Innovation Organization (BIO). With more than half a billion in annual ...

We are thrilled to be hosting great networking events in Washington D.C. for IPCC 2024.

This is the only conference focused specifically on intellectual property in biotechnology, featuring the latest insights from biotech IP experts, as well as networking events designed to promote ...